Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Biosimilars

Biosimilars

ADVERTISEMENT
News and Trends

Alvotech and JAMP Pharma add two biosimilar candidates for Canadian market

Alvotech and the JAMP Pharma Group have expanded their exclusive partnership to commercialize biosimilars developed…

By Jim Cornall
October 20, 2022 - 2 minutes
News and Trends

FDA gives $1.3M grant to Biologics & Biosimilars Collective Intelligence Consortium

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) has received a major grant from the…

By Jim Cornall
October 4, 2022 - 2 minutes
More News!

The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech?

AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer…

By Clara Rodríguez Fernández
October 17, 2018 - 2 minutes
News and Trends

German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval

Cyltezo, an adalimumab biosimilar drug by Boehringer Ingelheim, has received the backing to be marketed…

By Alex Dale
September 18, 2017 - 1 minute
News and Trends

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

Samsung Bioepis has announced the European Commission approved Imraldi, a biosimilar of AbbVie's Humira (adalimumab),…

By Clara Rodríguez Fernández
August 28, 2017 - 2 minutes
News and Trends

Biosimilars Struggle to Substitute Brand-Name Drugs

Despite bringing a significant price reduction, biosimilars might lag in taking over the market of…

By Clara Rodríguez Fernández
August 16, 2017 - 2 minutes
News and Trends

Biosimilars set to take on Oncology after a new Market Authorization

The European Commission has approved Truxima, the world's first biosimilar monoclonal antibody (mAb)  with an…

By Melanie De Almeida
February 23, 2017 - 3 minutes
More News!

The FDA lays down Laws of Interchangeability: New Era for Biosimilars?

The new guidelines from the FDA on interchangeability may bring the US biosimilar market up…

By External Contributor
February 8, 2017 - 4 minutes
News and Trends

Sanofi Jumps into the Biosimilars Market aiming for Asia

Sanofi is joining the biosimilars trend to challenge Roche's best-selling biological with a partnership that…

By Clara Rodríguez Fernández
December 6, 2016 - 2 minutes
News and Trends

Boehringer’s Biosimilar could take a Chunk out of the Cancer Market

Boehringer Ingelheim is getting ready to launch a biosimilar for Roche's cancer blockbuster Avastin as…

By Clara Rodríguez Fernández
November 17, 2016 - 2 minutes
News and Trends

What’s in the Cards for a Biosimilar after it Launches

As legal frameworks and regulatory pathways for biosimilars are in evolving all around the world,…

By External Contributor
November 17, 2016 - 5 minutes
News and Trends

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

Sanofi and Regeneron (NY, US) have ruled their phase III clinical trial immunotherapy Sarilumab a…

By Dani Bancroft
October 31, 2016 - 3 minutes
  • 1
  • 2
  • 3
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days